| Announce Date | 11/13/2025 |
| EPS Normalized Actual | $-0.3 (Beat by $0.13) |
| EPS GAAP Actual | $-0.3 (Beat by $0.13) |
| Revenue Actual | $0.00284086B |
| Revenue Surprise | Beat by $2.84086M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.35 |
| EPS GAAP Estimate | $-0.35 |
| Revenue Estimate | $0.0063565B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 34.75 | 0.15 | 34.12191 | 35.37809 | 1 |
| Dec 2028 | 34.75 | 0.15 | 33.15331 | 36.34669 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.08 | 0.725 | 0.00284086B | 100% | 0.84M |
| FQ2 2025 (Jun 2025) | -0.65 | 0.19 | 0.00165769B | 100% | 0.71M |
| FQ1 2025 (Mar 2025) | -0.13 | 0.45 | 0.00292865B | 100% | 2.43M |
| FQ1 2020 (Jan 2020) | -0.0049 | -0.0049 | 0B | NAN% | 0M |
| FQ1 2021 (Mar 2021) | -7 | -7 | 0B | NAN% | 0M |
| FQ2 2021 (Jun 2021) | 0.0572 | 0.0572 | 0B | NAN% | 0M |
| FQ3 2021 (Sep 2021) | -2.07 | -2.07 | 0B | NAN% | 0M |
| FQ4 2021 (Dec 2021) | 0 | 0 | 0B | NAN% | 0M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.35
Consensus Revenue Estimates
0.0063565B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | -0.135 | -- | -0.14461 | -0.12531 | 1 |
| FQ3 2026 (Sep 2026) | -0.49 | 83.67 | -0.49 | -0.49 | 1 |
| FQ2 2026 (Jun 2026) | -0.59 | -10.17 | -0.59 | -0.59 | 1 |
| FQ1 2026 (Mar 2026) | -0.35 | 62.86 | -0.37492 | -0.32487 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.01B | -- | 0.01B | 0.01B | 1 |
| FQ3 2026 (Sep 2026) | 0.01B | 64.92 | 0.01B | 0.01B | 1 |
| FQ2 2026 (Jun 2026) | 0.01B | 75.09 | 0.01B | 0.01B | 1 |
| FQ1 2026 (Mar 2026) | 0.01B | 53.93 | 0.01B | 0.01B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
3
EPS # of in-lines
1
Revenue # of Beats
3
Revenue # of Misses
0
Revenue # of in-lines
5
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.805 | -0.08 | 0.725 | -906.25% |
| FQ2 2025 (Jun 2025) | -0.84 | -0.65 | 0.19 | -29.23% |
| FQ1 2025 (Mar 2025) | -0.58 | -0.13 | 0.45 | -346.15% |
| FQ1 2020 (Jan 2020) | -0.0049 | -0.0049 | 100% | |
| FQ1 2021 (Mar 2021) | -7 | -7 | 100% | |
| FQ2 2021 (Jun 2021) | 0.0572 | 0.0572 | 100% | |
| FQ3 2021 (Sep 2021) | -2.07 | -2.07 | 100% | |
| FQ4 2021 (Dec 2021) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0B | $0.84M | 29.6% |
| FQ2 2025 (Jun 2025) | $0B | $0B | $0.71M | 42.69% |
| FQ1 2025 (Mar 2025) | $0B | $0B | $2.43M | 82.93% |
| FQ1 2020 (Jan 2020) | $0B | $0B | $0M | NAN% |
| FQ1 2021 (Mar 2021) | $0B | $0B | $0M | NAN% |
| FQ2 2021 (Jun 2021) | $0B | $0B | $0M | NAN% |
| FQ3 2021 (Sep 2021) | $0B | $0B | $0M | NAN% |
| FQ4 2021 (Dec 2021) | $0B | $0B | $0M | NAN% |